Oct 2026· Diabetes Technology & Therapeutics· pp.
15209156261489912
· 0 citations· 21 references
Medicine
TL;DR
An inpatient CGM policy from an adult to pediatric hospital setting is translated, supporting high levels of protocol adherence, clinical accuracy, safety, and improved experiences for clinicians.
Abstract
Objective
We assessed the safety, clinical accuracy, glycemic outcomes, user outcomes, and implementation of a pediatric hospital-wide continuous glucose monitor (CGM) policy.
RESEARCH
Design
AND
Methods
We used the Model for Improvement to develop a pediatric hospital policy supporting CGM-based insulin dosing with accuracy validation using capillary finger-stick blood glucose (FSBG) and then retrospectively evaluated the program's clinical effectiveness and implementation outcomes with the Simplified Implementation Logic Model to connect contextual determinants, support strategies, and outcomes.
Results
From September 2024 to October 2025, 60 people with diabetes used the CGM policy in 93 hospital encounters, including 46.7% (28/60) people with type 1 diabetes and 38.7% (36/93) encounters with automated insulin delivery use. The most used CGMs were Dexcom G7 (49.5%) and Abbott Libre 3 or 3 Plus (31.2%). Accuracy validation using the %20/20 criteria was successful in 81.5% of attempts, and the mean absolute relative difference was 12.6%, with 1207 paired CGM and reference FSBG values. Nurses responded appropriately after 97.8% (218/223) of failed CGM validation attempts. CGM time in range (70-180 mg/dL) was 54.8%, and time in level 2 hypoglycemia (<54 mg/dL) was 0.8% for the 58 out of 93 encounters with complete CGM data downloads. Nurses preferred using CGM with policy support instead of FSBG for insulin dosing (adjusted P = 0.046). Factors contributing to nursing preference included ease of use, system integration, and the ability to learn the system quickly.
Conclusions
We translated an inpatient CGM policy from an adult to pediatric hospital setting, supporting high levels of protocol adherence, clinical accuracy, safety, and improved experiences for clinicians. Program evaluation informs connections between contextual determinants, support strategies, and outcomes of implementing a hospital CGM program. These data offer a roadmap for implementing pediatric hospital CGM at other centers.
In this pediatric hospital CGM accuracy study, MARD was within a favorable range of <14% overall and throughout sensor wear and hospitalization, highlighting the need to incorporate trend arrows into hospital CGM protocols.
Jessica L. Ruiz, A. Stein, Alexander Wheelock et al.· Diabetes Technology & Therap...· 0 citations
Topics covered include selection criteria for management with diabetes technologies, CGM-derived glycemic metrics and goals for adults with diabetes, insulin titration and administration guidelines, perioperative care, CGM alarm settings for hypoglycemia and hyperglycemia, clinical staff training and workflows, integra...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetes Care· 1 citation
BACKGROUND
In-hospital diabetes mellitus management currently relies on intermittent glucose monitoring with point-of-care (POC) testing, rather than continuous glucose monitoring (CGM). Most studies on CGM have focused on its benefits and accuracy in the outpatient setting, in contrast to the hospital setting, where t...
C. Pedersen, Aslak Johansen, A. Philipsen et al.· British Journal of Anaesthes...· 0 citations
There is an urgent and unmet need for a practical clinical guideline addressing the use of continuous glucose monitoring (CGM), insulin pumps and automated insulin delivery (AID) systems in hospital settings. The goal with this position statement is to facilitate effective and safe use of these devices to improve glyca...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetologia· 0 citations
Continuous glucose monitoring (CGM) has emerged as a promising approach for improving glycemic management in hospitalized individuals, with accumulating evidence supporting its role in reducing hypoglycemia and improving glycemic control. However, the inpatient setting presents unique challenges, including hemodynamic...
Jee Hee Yoo, S. Moon, Da-Young Lee et al.· Journal of Korean Diabetes· 1 citation
BACKGROUND
Although continuous glucose monitoring (CGM) is well established for insulin-treated diabetes, its utility in non-insulin-treated type 2 diabetes (T2D) remains less studied.
OBJECTIVE
To evaluate the short-term clinical and economic outcomes following personal use of CGM in patients with T2D.
METHODS
Thi...
S. Gadd, Connor W. Willis, Ishfaq Rashid et al.· Journal of Managed Care & Sp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.